CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

BAP1

CIViC ID: 70 · Entrez: 8314

Aliases: HUCEP-13,UCHL2,hucep-6,BAP1,KURIS,TPDS1,UVM2,UBM2

Description

BAP1 is a deubiquitylase thought to be a key regulator of many cancer-associated pathways. Germline alterations in BAP1 have been characterized as predisposing variants to familial melanocytic skin tumors. These alterations also have been linked to the development of mesothelioma, uveal melanoma, cutaneous melanoma and others. Clinically, the role of BAP1 is still being investigated. However, the development of intradermal tumors known as melanocytic BAP1-associated intradermal tumors (MBAITs) are enough for a patient to be subject to more intense surveillance to catch other malignancies as early as possible.

Cyan = gene  ·  Slate = variant  ·  Green = drug  ·  Click variant to filter table

Variants (5)

CIViC IDNameHGVSType(s)
2211ALTERNATIVE TRANSCRIPT (ATI)
182EXPRESSION
2212Loss
5118Loss-of-function
183Mutationprotein_altering_variant,loss_of_function_variant